Formulary Search Results for: ULIPRISTAL ACETATE
13.6.1 Topical preparations for acne - View Category
Preferred List
8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists - View Category
Total Formulary
ABIRATERONE ACETATE (tablets)
Restrictions:
Restricted to specialist use in accordance with regional protocol [NHS network access required] for the indications below:
Metastatic castration resistant prostate cancer (mCRPC):
- Use in adult men in whom chemotherapy is not yet clinically indicated after failure of androgen deprivation therapy.
- Use in adult men who have received only one prior chemotherapy regimen.
- With prednisone or prednisolone for the treatment of newly diagnosed high-risk metastatic hormone sensitive prostate cancer in adult men in combination with androgen deprivation therapy.
Non-metastatic prostate cancer:
- Use of abiraterone acetate plus prednisolone in combination with androgen deprivation therapy for the treatment of high-risk hormone-sensitive non-metastatic prostate cancer (off label indication as approved by NCMAG).
Metastatic prostate cancer:
- Abiraterone acetate plus prednisolone in combination with androgen deprivation therapy for the treatment for newly diagnosed low-risk metastatic hormone-sensitive prostate cancer patients who are not suitable for currently accessible on-label alternatives (off label indication as approved by NCMAG).
